Glenmark Pharma Latest News

  1. The Horizant market achieved annual sales of approximately $99.5 million
    Date:31-12-2020
  2. The Horizant market achieved annual sales of approximately $99.5 million
    Date:31-12-2020
  3. The Cialis Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg market achieved annual sales of approximately $125.5 million
    Date:31-12-2020
  4. The fixed drug combination is indicated for the management of Type 2 diabetes
    Date:29-12-2020
  5. The fixed drug combination is indicated for the management of Type 2 diabetes
    Date:29-12-2020
  6. Glenmark Pharmaceuticals has informed that the company has attached media release on 23rd December 2020, titled ‘Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializi...

    Date:23-12-2020
  7. Glenmark will be responsible for the continued development and regulatory approval of Ryaltris in these markets
    Date:23-12-2020
  8. Glenmark will be responsible for the continued development and regulatory approval of Ryaltris in these markets
    Date:23-12-2020
  9. The 12 month period ending October 2020, the Pradaxa Capsules, 75 mg, 110 mg, and 150 mg market achieved annual sales of approximately $550.9 million
    Date:21-12-2020
  10. The 12 month period ending October 2020, the Pradaxa Capsules, 75 mg, 110 mg, and 150 mg market achieved annual sales of approximately $550.9 million
    Date:21-12-2020
Return to Top
Puchho Befikar